Good test this week to see share price finish above $4
Next test is $4.50 we need to push through here at some point.
Conservatively we should be $5-6 now in my view, so still undervalued others valuation are $6+
Lot of news to come in coming weeks/months so we should see it push on from here.
Think $8 by mid year is not unreasonable with the right news flow, some analysts posted on this forum are saying $10 target over next 3 months....
By this time next year we will have hopefully accomplished some significant milestones, with ROW licensing/market stitched up, market space possibly tripling our current US deal, FDA approval Trof, results from NZ-2591 4/IND's, cash milestone $110m, forecast revenue/income stream from both licensing deals for CY2023-24 and on......
2023= cash in the bank, Trof asset ready to enter market sales/revenue forecast, possible phase 3 ready Block Buster!
Smooth run here will see market cap $2b easy, this market cap could be applied just from Trof asset alone with cash $110 m in the bank and market ready asset....NZ-2591 if its future looks bright, our market cap should $4b
Big 12 months, big gap in share price from $4.16 today to $16, it essentially has to go up on average $1 per month, not unreasonable given the low base and the news flow....
Good test this week to see share price finish above $4Next test...
Add NEU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$20.68 |
Change
-0.100(0.48%) |
Mkt cap ! $2.643B | |||
| Open | High | Low | Value | Volume |
| $20.50 | $20.74 | $20.01 | $5.091M | 247.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 156 | $20.67 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $20.68 | 256 | 1 |
View Market Depth
| Last trade - 16.10pm 19/07/2024 (20 minute delay) ? |
| NEU (ASX) Chart |